Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) hit a new 52-week low on Tuesday . The stock traded as low as $7.1780 and last traded at $7.22, with a volume of 24762 shares trading hands. The stock had previously closed at $7.59.
Analysts Set New Price Targets
Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a report on Wednesday, January 28th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on CLPBY
Coloplast A/S Stock Up 1.2%
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last issued its quarterly earnings results on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%.The firm had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.12 billion. As a group, sell-side analysts expect that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current year.
Coloplast A/S Company Profile
Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.
In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.
Read More
- Five stocks we like better than Coloplast A/S
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
